GLP-1 and Levothyroxine: Can You Take Them Together?

The Overlap: Hypothyroidism and Obesity

Hypothyroidism affects about 5% of the US population, with Hashimoto's thyroiditis being the most common cause. One of the hallmark symptoms of hypothyroidism is weight gain, and many patients struggle to lose weight even after achieving normal thyroid hormone levels with levothyroxine. This makes GLP-1 medications an attractive option for this population.

The good news: there are no direct drug interactions between GLP-1 receptor agonists and levothyroxine. However, there are important timing and monitoring considerations.

How GLP-1 Medications May Affect Levothyroxine

Gastric Emptying and Absorption

GLP-1 medications slow gastric emptying — the rate at which food and medications leave the stomach. Since levothyroxine is absorbed primarily in the small intestine, delayed gastric emptying could theoretically alter its absorption. However, this is mainly a concern for oral GLP-1 medications like Rybelsus (oral semaglutide).

For injectable GLP-1s (Wegovy, Ozempic, Mounjaro, Zepbound), the impact on levothyroxine absorption is minimal because:

• Levothyroxine is taken orally on an empty stomach, 30-60 minutes before eating
• Injectable GLP-1s do not directly interact with oral medication absorption in the gut
• The delayed gastric emptying effect is most pronounced with food, not with medications taken on an empty stomach

Weight Loss and Dose Requirements

This is the most important consideration. As you lose weight on a GLP-1 medication, your body mass decreases, and your levothyroxine requirements may change:

• Lower body weight = lower levothyroxine dose needed — Levothyroxine dosing is weight-based (typically 1.6 mcg/kg/day)
• Changes in absorption — Weight loss can alter gut physiology and medication absorption
• Metabolic rate changes — Weight loss reduces overall metabolic rate, which may affect thyroid hormone utilization

If your levothyroxine dose is too high after significant weight loss, you may develop symptoms of hyperthyroidism (anxiety, palpitations, sweating, insomnia). If it's too low, you may experience fatigue, cold intolerance, and slowed weight loss.

Best Practices for Taking Both Medications

1. Timing Is Key

Take levothyroxine first thing in the morning on an empty stomach, at least 30-60 minutes before eating or taking other medications. If you take oral semaglutide (Rybelsus), take it at least 30 minutes after levothyroxine, on an empty stomach, with no more than 4 oz of water.

For injectable GLP-1s, the timing is more flexible. You can inject at any time of day, with or without food. Many patients find it convenient to inject in the morning after their levothyroxine wait period.

2. Monitor Thyroid Levels Regularly

Your doctor should check your thyroid panel:

• Before starting GLP-1 — Baseline TSH, free T3, free T4
• 6-8 weeks after starting — To catch any early changes
• Every 3-6 months during active weight loss — To adjust levothyroxine as needed
• After significant weight loss milestones — Every 10-15% body weight lost

3. Watch for Symptoms of Over-Replacement

As you lose weight, watch for signs that your levothyroxine dose may be too high:

• Rapid heartbeat or palpitations
• Anxiety or irritability
• Excessive sweating
• Insomnia
• Tremors
• Heat intolerance
• Unexplained weight loss beyond what's expected from GLP-1

If you experience these symptoms, contact your doctor immediately for a thyroid panel.

4. Don't Stop Either Medication Without Consulting Your Doctor

Never stop levothyroxine or your GLP-1 medication without medical supervision. Untreated hypothyroidism can cause weight gain, fatigue, and serious health complications. Stopping GLP-1s abruptly can lead to rebound weight gain.

What About Hashimoto's Thyroiditis?

Hashimoto's thyroiditis is the most common cause of hypothyroidism in the US. Many people with Hashimoto's wonder if GLP-1 medications are safe for them. The answer is yes:

• GLP-1 medications do not affect autoimmune thyroid function
• The FDA boxed warning about thyroid C-cell tumors relates to medullary thyroid carcinoma (MTC), not Hashimoto's
• GLP-1s are not contraindicated for patients with Hashimoto's, hypothyroidism, or any non-MTC thyroid condition
• Some research suggests GLP-1s may even have anti-inflammatory effects that could benefit autoimmune conditions

What About Other Thyroid Medications?

• Levothyroxine (Synthroid, Levoxyl, Tirosint): Safe with GLP-1s. Monitor TSH with weight loss.
• Liothyronine (Cytomel, T3): Safe with GLP-1s. Same monitoring approach.
• Desiccated thyroid (Armour, NP Thyroid): Safe with GLP-1s. Monitor TSH and T3 levels.
• Methimazole or PTU (for hyperthyroidism): Consult your endocrinologist. GLP-1s may be contraindicated depending on your condition.

Can GLP-1 Medications Cause Thyroid Problems?

The FDA boxed warning on all GLP-1 medications states that they caused thyroid C-cell tumors in rats and mice. However:

• This has not been confirmed in humans despite millions of users worldwide
• GLP-1 medications do not cause hypothyroidism or Hashimoto's
• GLP-1s do not affect TSH, T3, or T4 levels directly
• The contraindication is specifically for medullary thyroid carcinoma (MTC) and MEN2 syndrome
• Patients with hypothyroidism from any cause (Hashimoto's, post-thyroidectomy, etc.) can safely take GLP-1s

Ready to Start Your GLP-1 Journey?

If you have hypothyroidism and are considering GLP-1 medications for weight loss, check your eligibility with a US-licensed telehealth provider. Be sure to mention your thyroid condition and current medications.